Crystal structure of Streptococcus pneumoniae pneumolysin provides key insights into early steps of pore formation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lawrence, Sara L ^a   Feil, Susanne C ^a   Morton, Craig J ^a   Farrand, Allison J ^b   Mulhern, Terrence D ^c   Gorman, Michael A ^a   Wade, Kristin R ^b   Tweten, Rodney K ^b   Parker, Michael W ^a,c  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBOHYDRATE; MANNOSE; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; PROTEIN BINDING; SOLUTION AND SOLUBILITY; STREPTOLYSIN;

BINDING SITE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR DOCKING; MOLECULAR MODEL; MUTATION; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SOLUTION AND SOLUBILITY; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

BACTERIAL PROTEINS; BINDING SITES; CARBOHYDRATES; CRYSTALLOGRAPHY, X-RAY; MANNOSE; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SOLUTIONS; STREPTOLYSINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84942755927     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14352     Document Type: Article

References (63)

1. Miller, E., Waight, P., Efstratiou, A., Brisson, M., Johnson, A. Epidemiology of invasive and other pneumococcal diseases in children in England and Wales 1996-1998. Acta Paediatr. Suppl. 89, 11-16 (2000).
2. Hirst, R. A., Kadioglu, A., O'Callaghan, C., Andrew, P. W. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin. Experiment. Immunol. 138, 195-201 (2004).
3. Ramachandran, R., Heuck, A. P., Tweten, R. K., Johnson, A. E. Membrane dependent conformational changes initiate cholesterol-dependent cytolysin oligomerisation and intersubunit beta-strand alignment. Nat. Struct. Biol. 11, 697-705 (2004).
4. Tweten, R. K. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect. Immun. 73, 6199-6209 (2005).
5. Shepard, L. A. et al. Identification of a membrane-spanning domain of the thiol activated pore-forming toxins: Clostridium perfringens, perfringolysin O: an alpha helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry 37, 14563-14574 (1998).
6. Shatursky, O. et al. The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for poreforming toxins. Cell 99, 293-299 (1999).
7. Tilley, S. J., Orlova, E. V., Andrew, P. W., Saibil, H. R. Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121, 247-256 (2005).
8. Giddings, K. S., Johnson, A. E., Tweten, R. K. Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins. Proc. Natl. Acad. Sci. USA 100, 11315-11320 (2003).
9. Farrand, A. J., LaChapelle, S., Hotze, E. M., Johnson, A. E., Tweten, R. K. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc. Natl. Acad. Sci. USA 107, 4341-4346 (2010).
10. Alouf, J. E., Billington, S. J., Jost, B. H. Repertoire and general feature of the family of cholesterol-dependent cytolysins in The Comprehensive Sourcebook Of Bacterial Protein Toxins (eds Alouf, J. E., Popoff, M. R.) 643-658 (Acadamic Press, Oxford, England, 2005).
11. Ramachandran, R., Heuck, A. P., Tweten, R. K., Johnson, A. E. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. Nature Struct. Biol. 9, 823-827 (2002).
12. Nollmann, M., Gilbert, R., Mitcell, T., Sferrazza, M., Byron, O. The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin. Biophys. J. 86, 3141-3151 (2004).
13. Dowd, K. J., Farrand, A. J., Tweten, R. K. The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly. PLoS Pathog. 8, e1002787 (2012).
14. Giddings, K. S., Zhao, J., Sims, P. J., Tweten, R. K. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat. Struct. Mol. Biol. 11, 1173-1177 (2004).
15. Rosado, C. J. et al. A common fold mediates vertebrate defense and bacterial attack. Science 317, 1548-1551 (2007).
16. Hadders, M. A., Beringer, D. X., Gros, P. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science 317, 1552-1554 (2007).
17. Polekhina, G., Giddings, K. S., Tweten, R. K., Parker, M. W. Insights into the action of the superfamily of cholesterol-dependent cytolysins from studies of intermedilysin. Proc. Natl. Acad. Sci. USA 102, 600-605 (2005).
18. Wickham, S. E. et al. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8? and C9. J. Biol. Chem. 286, 20952-20962 (2011).
19. Johnson, S., Brooks, N. J., Smith, R. A., Lea, S. M., Bubeck, D. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59. Cell Rep. 3, 1369-1377 (2013).
20. Shewell, L. K. et al. The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity. Proc. Natl. Acad. Sci. USA 111, E5312-20 (2014).
21. Lim, J. E., Park, S. A., Bong, S. M., Chi, Y. M., Lee, K. S. Characterization of pneumolysin from Streptococcus pneumoniae, interacting with carbohydrate moiety and cholesterol as a component of cell membrane. Biochem. Biophys. Res. Communs. 430, 659-663 (2012).
22. Rossjohn, J., Feil, S. C., McKinstry, W. J., Tweten, R. K., Parker, M. W. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89, 685-692 (1997).
23. Bourdeau, R. W. et al. Cellular functions and X-ray structure of anthrolysin O, a cholesterol-dependent cytolysin secreted by Bacillus anthracis. J. Biol. Chem. 284, 14645-14656 (2009).
24. Xu, L. et al. Crystal structure of cytotoxin protein suilysin from Streptococcus suis. Protein Cell 1, 96-105 (2010).
25. Feil, S. C., Ascher, D. B., Kuiper, M. J., Tweten, R. K., Parker, M. W. Structural studies of Streptococcus pyogenes streptolysin O provides insights into the early steps of membrane penetration. J. Mol. Biol. 426, 785-792 (2014).
26. Köster, S. et al. Crystal structure of listeriolysin O reveals molecular details of oligomerisation and pore formation. Nature Commun. 5, 3690 (2014).
27. Rossjohn, J. et al. Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins. J. Mol. Biol. 367, 1227-1238 (2007).
28. Wade, K. R. et al. An intermolecular electrostatic interaction controls the prepore-to-pore transition in a cholesterol-dependent cytolysin. Proc. Natl. Acad. Sci. USA 112, 2204-2209 (2015).
29. Lawrence, M. C., Colman, P. M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234, 946-950 (1993).
30. Gilbert, R. J. et al. Self-interaction of pneumolysin, the pore forming protein toxin of Streptococcus pneumoniae. J. Mol. Biol. 284, 1223-1237 (1998).
31. Shepard, L. A., Shatursky, O., Johnson, A. E., Tweten, R. K. The mechanism of pore assembly for a cholesterol-dependent cytolysin: formation of a large prepore complex precedes the insertion of the transmembrane ?-hairpins. Biochemistry 39, 10284-10293 (2000).
32. Hotze, E. et al. Monomer-monomer interactions propagate structural transitions necessary for pore-formation by the cholesteroldependent cytolysins. J. Biol. Chem. 287, 24534-24543 (2012).
33. Gunn, N. J., Gorman, M. A., Dobson, R. C. J., Parker, M. W., Mulhern, T. D. Purification, crystallisation, small-angle scattering and preliminary X-ray diffraction analysis of the SH2 domain of Csk-homologous kinase. Acta Crystallogr. F 67, 336-339 (2011).
34. Petoukhov, M. V. et al. New developments in the ATSAS program package for small-angle scattering data analysis. J. Appl. Cryst. 45, 342-350 (2012).
35. Mylonas, E., Svergum, D. I. Accuracy of molecular mass determination of proteins in solution by small-angle X-ray scattering. J. Appl. Cryst. 40, s245-s249 (2007).
36. Franke, D., Svergun, D. I. DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. J. Appl. Cryst. 42, 342-346 (2009).
37. Svergun, D., Barberato, C., Koch, M. H. J. CRYSOL-a Program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Cryst. 28, 768-773 (1995).
38. Tsai, K. C. et al. Prediction of carbohydrate binding sites on protein surfaces with 3-dimensional probability density distributions of interacting atoms. PLoS ONE 7, e40846 (2012).
39. Solovyova, A. S., Nöllmann, M., Mitchell, T. J., Byron, O. The solution structure and oligomerization behaviour of two bacterial toxins: pneumolysin and perfringolysin O. Biophys. J. 87, 540-552 (2004).
40. Gilbert, R. J. et al. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. Cell 97, 647-655 (1999).
41. Kirkham, L. A. et al. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect. Immun. 74, 586-593 (2006).
42. Malik, A., Ahmad, S. Sequence and structural features of carbohydrate binding in proteins and assessment of predictability using a neural network. BMC Struct. Biol. 7, 1 (2007).
43. Iwamoto, M., Ohno-Iwashita, Y., Ando, S. Role of the essential thiol group in the thiol-activated cytolysin from Clostridium perfringens. Eur. J. Biochem. 167, 425-430 (1987).
44. Sekino-Suzuki, N., Nakamura, M., Mitsui, K. I., Ohno-Iwashita, Y. Contribution of individual tryptophan residues to the structure and activity of theta-toxin (perfringolysin o), a cholesterol-binding cytolysin. Eur. J. Biochem. 241, 941-947 (1996).
45. Jacobs, T. et al. The conserved undecapeptide shared by thiol-activated cytolysins is involved in membrane binding. FEBS Lett. 459, 463-466 (1999).
46. Norcross, E. W. et al. Active immunization with pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae keratitis. Invest. Ophthalmol. Vis. Sci. 52, 9232-9243 (2011).
47. Oloo, E. O., Yethon, J. A., Ochs, M. M., Carpick, B., Oomen, R. Structure-guided antigen engineering yields pneumolysin mutants suitable for vaccination against pneumococcal disease. J. Biol. Chem. 286, 12133-12140 (2011).
48. Salha, D. et al. Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury. Infect. Immun. 80, 2212-2220 (2012).
49. Goulart, C. et al. Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives. PLoS One 8, e59605 (2013).
50. Neill, D. R., Smeaton, S., Bangert, M., Kadioglu, A. Nasopharyngeal carriage with Streptococcus pneumoniae augments the immunizing effect of pneumolysin toxoid B. J. Allergy Clin. Immunol. 131, 1433-1435 (2013).
51. Mann, B. et al. Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein. J. Infect. Dis. 209, 1116-1125 (2014).
52. Kirby, N. M. et al. A low-background-intensity focusing small-angle X-ray scattering undulator beamline. J. Appl. Cryst. 46, 1670-1680 (2013).
53. Volkov, V. V., Svergun, D. I. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Crystallogr. 36, 860-864 (2003).
54. McPhillips, T. M. et al. Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines. J. Synchrotron Radiat. 9, 401-406 (2002).
55. Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D. Biol. Crystallogr. 66, 133-144 (2010).
56. Matthews, B. W. Solvent contents of protein crystal. J. Mol. Biol. 33, 491-497 (1968).
57. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
58. Emsley, P., Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
59. Adams, P. D. et al. PHENIX: building a software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948-1954 (2002).
60. Laskowski, R. A., MacArthur, M. W., Moss, D. S., Thornton, J. M. PROCHECK: a program to check the sterochemical quality of protein structures. J. Appl. Cryst. 26, 283-291 (1993).
61. Jain, A. N. Surflex-Dock 2.1: robust performance from ligand energetic modelling, ring flexibility, and knowledge-based search. J. Comput. Aided Mol. Des. 21, 281-306 (2007).
62. Baker, N. A., Sept, D., Joseph, H., Holst, M. J., McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 98, 10037-10041 (2001).
63. Svergun, D. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495-503 (1992).